Valuation: Lead Data Inc.

Market Cap 54Cr 1.65Cr 1.48Cr 1.36Cr 1.24Cr 2.31Cr 156.9Cr 2.35Cr 16Cr 6.5Cr 82Cr 6.2Cr 6.07Cr 259.17Cr P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 57Cr 1.74Cr 1.56Cr 1.44Cr 1.3Cr 2.44Cr 165.38Cr 2.48Cr 17Cr 6.85Cr 87Cr 6.54Cr 6.4Cr 273.18Cr EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+30.77% 1.65Cr
+1.10%-1.28%-18.04%+8.11% 18TCr
-0.74%+1.27%+1.85%+32.55% 12TCr
+0.39%+4.74%-19.43%+17.10% 12TCr
+2.29%+17.36%-41.94%+9.49% 9.12TCr
-1.78%-2.37%+1.31%+76.28% 6.46TCr
-1.06%+4.59%+13.36%+78.58% 5.61TCr
-0.40%+3.86%+6.77%-22.18% 5.46TCr
-0.49%+0.46%-11.85%+31.61% 4.36TCr
+0.17%+5.85%-4.92%-10.64% 3.4TCr
Average -1.04%+1.65%-7.29%+25.17% 7.58TCr
Weighted average by Cap. +0.21%+3.55%-11.32%+22.85%

Financials

2024 2025
Net sales 1.55Cr 5L 4L 4L 4L 7L 4.5Cr 7L 47.1L 18.65L 2.36Cr 17.81L 17.43L 7.44Cr 11Cr 33.96L 30.32L 28.01L 25.39L 47.49L 32Cr 48.28L 3.37Cr 1.33Cr 17Cr 1.27Cr 1.25Cr 53Cr
Net income -13Cr -41.04L -36.65L -33.86L -30.68L -57.41L -39Cr -58.36L -4.07Cr -1.61Cr -20Cr -1.54Cr -1.51Cr -64Cr -4.4Cr -13.5L -12.06L -11.14L -10.1L -18.89L -13Cr -19.2L -1.34Cr -53.08L -6.72Cr -50.68L -49.6L -21Cr
Net Debt -1.7Cr -5L -5L -4L -4L -7L -4.94Cr -7L -51.63L -20.44L -2.59Cr -19.52L -19.1L -8.16Cr 2.91Cr 9L 8L 7L 7L 12.49L 8.48Cr 12.7L 88.68L 35.11L 4.44Cr 33.53L 32.81L 14Cr
Projected Income Statement - Annual - Lead Data Inc.
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock